Viking Therapeutics - Press Releases
Viking Therapeutics is developing novel therapeutics for patients suffering from metabolic and endocrine disorders.
Viking Therapeutics, Inc. (VKTX) Latest Stock News & Headlines …
Get the latest Viking Therapeutics, Inc. (VKTX) stock news and headlines to help you in your trading and investing decisions.
Viking Therapeutics Reports New Data from VK2735 Obesity …
SAN DIEGO, Nov. 4, 2024 /PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced that new clinical data from the company's VK2735 obesity program were highlighted in two poster presentations ...
Viking Therapeutics to Present Data from Phase 2b VOYAGE …
3 days ago · Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced ...
News & Events - Viking Therapeutics InvestorRoom
Feb 27, 2024 · Study Achieves Primary and all Secondary Endpoints, Demonstrating Statistically Significant Reductions in Body Weight at all Doses as Compared to Placebo. Up to 13.1% Placebo-Adjusted Mean Weight Loss (14.7% From Baseline) Observed After 13 Weeks of Treatment; No Plateau Observed.
Viking Therapeutics Announces Results from Phase 1b Clinical …
Oct 9, 2024 · Viking Therapeutics, Inc. (Viking) (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today...
Viking Therapeutics to Present Data from Phase 2b VOYAGE …
3 days ago · Results to be Featured in Oral Late Breaker Presentation. SAN DIEGO, Nov. 12, 2024 /PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company ...
Viking Therapeutics' weight-loss pill shows 'great outcome' in trial
Nov 4, 2024 · Viking Therapeutics Inc. cheered analysts Monday after the biotech posted data on its oral weight-loss drug showing better-than-expected results from a Phase 1 trial. The news sent the stock ...
Viking Therapeutics’ stock soars 18% as data on oral weight-loss …
Oct 24, 2024 · Viking Therapeutics Inc.’s stock soared 18% Thursday, after the biotech, which is developing a weight-loss drug in pill form that has raised high hopes among analysts and investors, posted...
Did Viking Therapeutics Just Say "Checkmate" To Eli Lilly?
2 days ago · Viking Therapeutics (VKTX-6.60%) is a clinical-stage pharma company that's been eyeing the weight loss market for some time now. During its third-quarter earnings call a few weeks ago, Viking's ...